What Nexus Bioquest say about themselves
“Nexus BioQuest - immunology CRO providing contract research services for immune-oncology, autoimmunity & inflammation. Accelerate to clinic.”
Nexus Bioquest Limited
- Incorporated
- 25 May 2022 (4 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Accounts type
- Small
- Region
- Greater London
- Address
- 9th Floor107 CheapsideLondonEC2V 6DN
Website & contact details
- Website
Filing status
- Accounts due
- 30 June 2027
- Last accounts
- 30 September 2025
- Conf. stmt due
- 7 June 2027
- Last conf. stmt
- 24 May 2026
Officers 9 active
Officer details are public data from the Companies House register.
Director · Appointed 31 March 2023
South African
Born September 1962 (64)
Director · Appointed 24 November 2022
Also at Evidence Topco Limited · more companies
British
Born February 1970 (56)
Director · Appointed 15 July 2022
Also at Janic Cro Limited, Coronado Research Ltd
South African
Born August 1983 (43)
Director · Appointed 15 July 2022
British
Born November 1970
Director · Appointed 15 July 2022
British
Born September 1977 (49)
Austrian
Born November 1962
Williams, Neil Andrew, Professor
Director · Appointed 15 July 2022
British
Born April 1964 (62)
Corporate Secretary · Appointed 25 May 2022
Director · Appointed 25 May 2022
British
Born October 1960 (66)
Officer history (2 former)
2 June 2023
31 March 2023
24 November 2022
15 July 2022
Appointed Williams, Neil Andrew, Professor as Director
15 July 2022
15 July 2022
15 July 2022
15 July 2022
15 July 2022
15 July 2022
Resigned Wagner, Claus Friedrich as Director
25 May 2022
25 May 2022
25 May 2022
Appointed Wagner, Claus Friedrich as Director
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Former controllers (1)
15 July 2022
Financials
Balance sheet as at 30 September 2025 · small accounts
- Net Assets
- £3,363,233
- Cash
- £1,448,401
- Employees
- 34
- Debt Ratio
- 13%
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Fixed Assets | £1,141,205 | £1,201,922 | £1,504,537 |
| Current Assets | £2,702,605 | £1,821,121 | £1,806,799 |
| Debtors | £1,233,357 | £924,244 | £324,599 |
| Cash | £1,448,401 | £871,132 | £1,449,063 |
| Creditors (< 1 year) | £366,512 | £154,241 | |
| Creditors (> 1 year) | £111,018 | £58,000 | |
| Net Current Assets | £2,333,046 | £1,454,609 | £1,652,558 |
| Net Assets | £3,363,233 | £2,598,531 | |
| Shareholder Funds | £2,598,531 | £3,157,095 |
Filings
Filing history not loaded yet. See it on Companies House
Some other companies at this address
Other companies in this industry
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →